These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33439047)

  • 1. Impact of TIPS on Splenic Volume and Thrombocytopenia.
    Liu J; Ma J; Yang C; Ye T; Meng J; Shi Q; Xiong B
    AJR Am J Roentgenol; 2021 Mar; 216(3):698-703. PubMed ID: 33439047
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of transjugular intrahepatic portosystemic shunt on thrombocytopenia associated with cirrhosis.
    Karasu Z; Gurakar A; Kerwin B; Hulagu S; Jazzar A; McFadden R; Nour B; Sebastian A; Cassidy F; Stokes K; Van Thiel DH; Wright H
    Dig Dis Sci; 2000 Oct; 45(10):1971-6. PubMed ID: 11117569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spleen stiffness and splenoportal venous flow: assessment before and after transjugular intrahepatic portosystemic shunt placement.
    Ran HT; Ye XP; Zheng YY; Zhang DZ; Wang ZG; Chen J; Madoff D; Gao J
    J Ultrasound Med; 2013 Feb; 32(2):221-8. PubMed ID: 23341376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coated transjugular intrahepatic portosystemic shunt does not improve thrombocytopenia in patients with liver cirrhosis.
    Barney EJ; Little EC; Gerkin RD; Ramos AX; Kahn J; Wong M; Kolli G; Manch R
    Dig Dis Sci; 2012 Sep; 57(9):2430-7. PubMed ID: 22588242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Transjugular Intrahepatic Portosystemic Shunt on Platelet Counts in Patients With Liver Cirrhosis.
    Massoud OI; Zein NN
    Gastroenterol Hepatol (N Y); 2017 May; 13(5):286-291. PubMed ID: 28656025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
    Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
    World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short- and long-term hemodynamic effects of transjugular intrahepatic portosystemic shunts: a Doppler/manometric correlative study.
    Lafortune M; Martinet JP; Denys A; Patriquin H; Dauzat M; Dufresne MP; Colombato L; Pomier-Layrargues G
    AJR Am J Roentgenol; 1995 Apr; 164(4):997-1002. PubMed ID: 7726065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in hematologic and hemostatic parameters after transjugular intrahepatic portosystemic shunt (TIPS) implantation].
    Papp M; Mezei G; Udvardy M; Altorjay I
    Orv Hetil; 2003 Jul; 144(27):1341-5. PubMed ID: 12908147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transjugular Intrahepatic Portosystemic Shunt Placement in Patients with Schistosomiasis-Induced Liver Fibrosis.
    Liu J; Zhou B; Chen D; Zhou C; Shi Q; Zheng C; Feng G; Yuan F; Ge Y; Xiong B
    Cardiovasc Intervent Radiol; 2019 Dec; 42(12):1760-1770. PubMed ID: 31363898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of transjugular intrahepatic portosystemic shunt on secondary hypersplenism.
    Pursnani KG; Sillin LF; Kaplan DS
    Am J Surg; 1997 Mar; 173(3):169-73. PubMed ID: 9124620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis?
    Jabbour N; Zajko A; Orons P; Irish W; Fung JJ; Selby RR
    Dig Dis Sci; 1998 Nov; 43(11):2459-62. PubMed ID: 9824134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing Affects Measurement of Portal Pressure Gradient After Placement of Transjugular Intrahepatic Portosystemic Shunts in Patients With Portal Hypertension.
    Silva-Junior G; Turon F; Baiges A; Cerda E; García-Criado Á; Blasi A; Torres F; Hernandez-Gea V; Bosch J; Garcia-Pagan JC
    Gastroenterology; 2017 May; 152(6):1358-1365. PubMed ID: 28130066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portal pressure gradient and serum albumin: A simple combined parameter associated with the appearance of ascites in decompensated cirrhosis treated with transjugular intrahepatic portosystemic shunt.
    Zhao D; Zhang G; Wang M; Zhang C; Li J
    Clin Mol Hepatol; 2019 Jun; 25(2):210-217. PubMed ID: 30897897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis.
    Dissegna D; Sponza M; Falleti E; Fabris C; Vit A; Angeli P; Piano S; Cussigh A; Cmet S; Toniutto P
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):626-632. PubMed ID: 30550458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sonographic assessment of spleen stiffness before and after transjugular intrahepatic portosystemic shunt placement with or without concurrent embolization of portal systemic collateral veins in patients with cirrhosis and portal hypertension: a feasibility study.
    Novelli PM; Cho K; Rubin JM
    J Ultrasound Med; 2015 Mar; 34(3):443-9. PubMed ID: 25715365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
    Berres ML; Asmacher S; Lehmann J; Jansen C; Görtzen J; Klein S; Meyer C; Strunk HM; Fimmers R; Tacke F; Strassburg CP; Trautwein C; Sauerbruch T; Wasmuth HE; Trebicka J
    J Hepatol; 2015 Feb; 62(2):332-9. PubMed ID: 25457205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The stiffness of the liver and spleen on ARFI Imaging pre and post TIPS placement: a preliminary observation.
    Gao J; Ran HT; Ye XP; Zheng YY; Zhang DZ; Wang ZG
    Clin Imaging; 2012; 36(2):135-41. PubMed ID: 22370134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transjugular intrahepatic portosystemic shunt. Experiences at a liver transplantation center.
    Hidajat N; Vogl T; Stobbe H; Schmidt J; Wex C; Lenzen R; Berg T; Neuhaus P; Felix R
    Acta Radiol; 2000 Sep; 41(5):474-8. PubMed ID: 11016769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transjugular intrahepatic portal shunt in the treatment of portal hypertension due to cirrhosis: single center experience.
    Chen Y; Qiu H; Zhang X
    BMC Surg; 2019 Dec; 19(1):191. PubMed ID: 31830972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Course of platelet counts in cirrhotic patients after implantation of a transjugular intrahepatic portosystemic shunt--a prospective, controlled study.
    Gschwantler M; Vavrik J; Gebauer A; Kriwanek S; Schrutka-Kölbl C; Fleischer J; Madani B; Brownstone E; Tscholakoff D; Weiss W
    J Hepatol; 1999 Feb; 30(2):254-9. PubMed ID: 10068105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.